Chromatin-associated HMG-17 is a major regulator of homeodomain transcription factor activity modulated by Wnt/β-catenin signaling

Nucleic Acids Research

Volumn 36, Issue 2, 2008, Pages 462-476

  Amen, Melanie ^a   Espinoza, Herbert M ^a   Cox, Carol ^b   Liang, Xiaowen ^a   Wang, Jianbo ^a   Link, Todd M E ^c   Brennan, Richard G ^c   Martin, James ^a   Amendt, Brad A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; HIGH MOBILITY GROUP N2 PROTEIN; TRANSCRIPTION FACTOR PITX2; WNT PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHROMATIN; CONTROLLED STUDY; DNA BINDING; EMBRYO DEVELOPMENT; GENE EXPRESSION; HOMOZYGOSITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BETA CATENIN; CELL LINE; CELL NUCLEUS; CHO CELLS; CHROMATIN; CRICETINAE; CRICETULUS; DNA; GENE EXPRESSION REGULATION; HMGN2 PROTEIN; HOMEODOMAIN PROTEINS; HUMANS; PROTEIN STRUCTURE, TERTIARY; REPRESSOR PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TWO-HYBRID SYSTEM TECHNIQUES; WNT PROTEINS;

MUS;

EID: 39149125794     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm1047     Document Type: Article

References (42)

1. Shiàkawa,H., Herrera,J.E., Bustin,M. and Postnikov,Y. (2000) Targeting of high mobility group-14-17 proteins in chromatin is independent of DNA sequence. J. Biol. Chem., 275, 37937-37944.
2. Bustin,M. and Neihart,N.K. (1979) Antibodies against chromosomal HMG proteins stain the cytoplasm of mammalian cells. Cell, 16, 181-189.
3. Phair,R.D. and Mistell,T. (2060) High mobility of proteins in the mammalian cell nucleus. Nature, 404, 604-609.
4. Bustin,M. (2001) Chromatin unfolding and activation by HMGN* chromosomal proteins. Trends Biochem. Sci. 25, 431-437.
5. Lim,J.-H., West,K.L., Rubinstein,Y., Bergel,M., Postnikov,Y.V. and Busim,M. (2005) Chromosomal protein HMGN1 enhances the acetylation of lysine in histone H3. EMBO J., 24, 3038-3048.
6. Trieschmann,L., Postnikov,Y.V., Rickers,A. and Buslin,M. (1995) Modular structure of chromosomai proteins HMG-14. and HMG-17; definition of a trapscriptional activation domain distinct from the nucleosomal binding domain. Mol. Cell. Biol., 15, 6663-6669.
7. Catez,F., Yang,H., Tracey,K.J., Reeves,R., Misteli,T. and Bustin,M. (2004) Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin. Mol. Cell. Biol., 24 4321-4328.
8. Hock,R., Furusawa,T., Ueda,T. and Bustin,M. (2006) HMG chromosomal proteins in development and disease. Trends Cell Biol., 17, 72-79.
9. Lehtonen,S. and Lehtonen,E. (2001) HMG-17 is an early marker of inductive interactions in the developing mouse kidney. Differentiation, 67, 154-163.
10. Lehtonen,S., Oikkonen,V.M., Stapieton,M., Zerial,M. and Lehtonen,E. (1998) HMG-17, a chromosomal non-histone protein, shows developmental regulation during organogenesis. Int. J. Dev. Biol., 42, 775-782.
11. Espinoza,H.M., Ganga,M., Vadlamudi,U., Martin,D.M., Brooks,B.P., Semina,E.V., Murray,J.C. and Amendt,B.A. (2005) Protein kinase C phosphorylation modulates N- and C-terminal regulatory activities of the PITX2 homeodomain protein. Biochemistry, 44, 3942-3954.
12. Amendt,B.A., Sutherland,L.B. and Russo,A.F. (1999) Multifunctional role of the Pitx2 homeodomain protein C-terminal tail. Mol. Cell. Biol. 19, 7001-7010.
13. Ganga,M., Espinoza,H.M., Cox,C.J., Morton,L., Hjalt,T.A., Lee,Y. and Amendt,B.A. (2003) PITX2 isoform-spccific regulation of atrial natriuretic factor expression: Synergism and repression with Nkx2.5. J. Biol. Chem., 278, 22437-22445.
14. Berry,F.B., Lines,M.A., Oas,J.M., Footz,T., Underhill,D.A., Gage,P.J. and Walter,M.A. (2006) Functional interactions between FOXC1 and PITX2 underlie the sensitivity to FOXC1 gene dose in Axenfeld-Rieger syndrome and anterior segment dysgenesis. Hum. Mol. Genet., 15, 905-919.
15. Gage,P.J. and Camper,S.A. (1997) Pituitary homeobox 2, a novel member of the bicoid-related family of homeobox genes, is a potential regulator of anterior structure formation. Hum. Mol. Genet., 6, 457-464.
16. Logan,M., Pagan-Westphal,S.M., Smith,D.M., Paganessi,L. and Tabin,C.J. (1998) The transcription factor Pitx2 mediates situs-specific morphogenesis in response to left-right asymmetric signals. Cell, 94, 307-317.
17. Lu,M., Pressman,C., Dyer,R., Johnson,R.L, and Martin,J.F. (1999) Function of Rieger syndrome gene in left-right asymmetry and craniofacial development. Nature, 401, 276-278.
18. Lin,C.R., Kioussi,C., O'Connell,S., Briata,P., Szeto,D., Liu,F., Izpisua-Bebnonte,J.C. and Rosenfeld,M.G. (1999) Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature, 401, 279-282.
19. Cox,C.J., Espinoza,H.M., McWilliams,B., Chappell,K., Morton,L., Hjalt,T.A., Semina,E.V. and AmendtB.A. (2002) Differential regulation of gene expression by PITX2 isoforms. J. Biol. Chem., 277, 25001-25010.
20. Tremblay,J.J., Goodyer,C.G. and Drouin,J. (2000) Transcriptional properties of Ptx1 and Ptx2 isoforms. Neupoendocrinology, 71 277-286.
21. Green,P.D., Hjalt,T.A., Kirk,D.E., Sutherland,L.B., Thomas,B.L., Sharpe,P.T., Snead,M.L., Murray,J.C., Russo,A.F. et al. (2001) Antagonistic regulation of Dlx2 expression by PITX2 and Msx2: impliuations; for tooth development. Gene Expr., 9, 265-281.
22. Vadlamudi,U., Espinoza,H.M., Ganga,M., Martin,D.M., Liu,X., Engelhardt,J.F. and Amendt,B.A. (2005) PITX2, β-catenin, and LEF-1 interact to synergistically regulate the LEF-1 promoter. J. Cell Sci. 118, 1129-1137.
23. Olson,L.E., Tollkuhn,J., Scafoglio,C., Krones,A., Zhang,J., Ohgi,K.A., Wu,W., Taketo,M.M., Kemler,R. et al. (2006) Homeodomain-mediated β-catenin-dependent switching events dictate cell-linage determination. Cell, 125, 593-605.
24. Amendt,B.A., Sutherland,L.B., Semina,E. and Russo,A.F. (1998) The molecular basis of Rieger Syndrome: Analysis of Pitx2 homeodomain protein activities. J. Biol. Chem., 273, 20066-20072.
25. Hjalt,T.A., Semina,E.V., Amendt,B.A. and Murray,J.C. (2000) The Pitx2 protein ih mouse development. Dev. Dyn., 218, 195-200.
26. Filali,M., Cheng,N., Abbott,D., Leontiev,V. and Engelhardt,J.F. (2002) Wnt-3A/β-catenin signaling induces transcription from the LEF-1 promoter. J. Biol. Chem., 277, 33398-33410.
27. Warden,S. and Homberg,U. (1993) A simple method for immunofluorescent double staining with primary antisera from the same species. J. Himochem. Cytochem., 41, 627-630.
28. Huffman,J.I., Mokashi,A., Bachinger,H.P. and Brennan,R.G. (2001) The basic helix-loop-helix domain of the ayl hydrocarbon receptor nuclear transporter (ARNT) can oligomerize and bind E-box DNA specifically. J. Biol Chem., 276, 40537-40544.
29. Lundblad,J.R., Laurance,M. and Goodman,R.H. (1996) Fluorescence polarization analysis of protein-DNA and protein-protein interactions. Mol. Endocrinol., 10, 607-612.
30. Segel,I.H. (1976) Biochemiral Calculatiora, 2nd edn. John Wiley and Sons Inc., New York, NY, p., 246-256.
31. Diamond,E., Amen,M., Hu,Q., Espinoza,H.M. and Amendt,B.A. (2006) Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2. Nucleic Acidy Res., 34, 5951-5965.
32. Amendt,B.A., Semina,E.V. and Alward,W.L.M. (2000) Rieger Syndrome: A clinical, molecular and biochemical analysis. Cell. Mol. Life Sci. 57, 1652-1666.
33. Amen,M., Liu,X., Vadlamudi,U., Elizondo,G., Diamond,E., Engethardt,T'.F. and Amendt,B.A. (2007) PITX2 and β-catenin interactions regulate Lef-1 isoform expression. Mol. Cell. Biol., 27, 7560-7573.
34. Liu,C., Li,Y., Semenov,M., Han,C., Baeg,G.-H., Tan,Y., Zhang,Z., Lin,X. and He,X. (2002) Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell, 109, 837-847.
35. Postnikov,Y.V., Herrera,J.E., Hock,R., Scheer,U. and Bustin,M. (1997) Clusters of nucleosomes containing chromosomal protein HMG-17 in chromatin. J. Mol. Biol., 274, 454-45.
36. Hock,R., Wilde,F., Scheer,U. and Bustin,M. (1998) Dynamic relocation of chromosomal protein HMG-17 in the nucleus is dependent on transcriptional activity. EMBO J., 17, 6992-7001.
37. Hjalt,T.A., Amendt,B.A. and Murray,J.C. (2001) Regulates procollagen lysyl hydroxylase (PLOD) gene expression: Implications for the pathology of Rieger Syndrome. J. Cell Biol., 152, 545-552.
38. Herrera,J.E., Sakaguchi,K., Bergel,M., Trieschmann,L., Nakatani,Y. and Bustin,M. (1999) Specific acetylation of chromosomal protein HMG-17 by PCAF alters its interaction with nucleosomes. Mol. Cell. Biol., 19, 3466-3473.
39. Trieschmann,L., Martin,B. and Bustin,M. (1998) The chromatin unfolding domain of chromosomal protein HMG-14 targets the N-terminal tail of histone H3 in nucleosornes. Proc. Nad Acad. Sci. USA, 95, 5468-5473.
40. Misteli,T. and Spector,D.L. (1998) The cellular organization of gene expression. Curr. Opin. Cell. Biol., 10, 323-331.
41. Wibmuller,S., Kosian,T., Wolf.M., Finzsch,M. and Weguer,M. (2006) The high-mobility-group domain of SQx proteins interacts with DNA-binding domains of many trasscription factos. Nucleic Acids Res., Y3 1735-1744.
42. Mohamed,O.A., Bustin,M. ancl Clarke,H.J. (2001) High-mobility group proteins 14 and 17 maintain the timing of early embryonic development in the mouse. Dev. Bio., 229, 237-249.